In the context of severe asthma, one of the causes of poor disease control has been identified in mucus plugs, which are real obstacles to the physiological flow of air in the bronchi. This clinical
Published: April 27, 2025 Explor Asthma Allergy. 2025;3:100980
Asthma is a prevalent chronic respiratory condition in children, often exacerbated by allergic reactions, with house dust mites (HDMs) being a significant trigger. Traditional asthma management prim
Published: April 26, 2025 Explor Asthma Allergy. 2025;3:100979
Aim:
Emerging epidemiological studies have reported a link between allergic diseases, including asthma, and depression. Evidently, the gut microbiota is involved in the pathogenesis of asthma and
Published: April 16, 2025 Explor Asthma Allergy. 2025;3:100978
Thanks to improvements in asthma care and availability of new biologic treatments, a relatively novel population of adolescents and young adults (AYA) with severe asthma (SA) is growing. Transition
Published: April 14, 2025 Explor Asthma Allergy. 2025;3:100977
Aim:
This study aims to investigate the impact of asthma on quality of life, explore its associations with anxiety and depression, and identify the key determining factors.
Methods:
A cross
Published: April 09, 2025 Explor Asthma Allergy. 2025;3:100976
A high percentage of patients with severe asthma also suffer from nasal polyposis, with dupilumab, an anti-IL-4R antibody both diseases can be treated due to its role in type 2 (T2) inflammation. Wh
Published: March 20, 2025 Explor Asthma Allergy. 2025;3:100975
Asthma is one of the most common respiratory diseases in humans throughout the world. The illness continues to be the most prevalent cause of respiratory morbidity and affects both adults and childr
Published: February 20, 2024 Explor Asthma Allergy. 2024;2:9–32
Lettuce allergy is uncommon and usually attributed to lipid transfer protein (LTP) sensitization. Most LTP-sensitized patients present with heterogeneous symptoms not only to lettuce, but to a large
Published: April 26, 2023 Explor Asthma Allergy. 2023;1:20–27
Seaweed, a rich source of bioactive compounds, has gained increasing attention for its potential therapeutic applications in allergy and inflammation. This review examines the current scientific lit
Published: April 23, 2024 Explor Asthma Allergy. 2024;2:127–147
Steroid-resistant asthma (SRA) is clinically significant, approximately 10–15% of individuals with asthma do not exhibit a positive response to standard treatments. While this subset represents a
Published: November 20, 2023 Explor Asthma Allergy. 2023;1:174–185
Multiple chemical sensitivity (MCS) is an unexplained acquired medical condition that includes multiple, vague, recurrent, and non-specific symptoms in different organs. They are attributed to expos
Published: July 29, 2024 Explor Asthma Allergy. 2024;2:350–362
Eosinophilic granulomatosis with polyangiitis (EGPA) is a multiorganic syndrome that affects the cardiovascular, neurologic, renal, and gastrointestinal systems with an incidence ranging from 0 case
Published: June 08, 2023 Explor Asthma Allergy. 2023;1:31–48
Allergen-specific immunotherapy (AIT) is a proven efficacy treatment for allergic rhinitis (AR), asthma, and Hymenoptera venom allergy, but its use in food allergy (FA) is still under investigation.
Published: October 20, 2023 Explor Asthma Allergy. 2023;1:126–141
Eosinophilic granulomatosis with polyangiitis (EGPA) is a multiorganic syndrome that affects the cardiovascular, neurologic, renal, and gastrointestinal systems with an incidence ranging from 0 case
Published: June 08, 2023 Explor Asthma Allergy. 2023;1:31–48
Allergen-specific immunotherapy for inhalant allergies, using allergen extracts of proven value, is highly effective in selected patients with allergic rhinoconjunctivitis and allergic asthma. Both
Published: February 29, 2024 Explor Asthma Allergy. 2024;2:76–84
Atopic dermatitis (AD) is a chronic inflammatory skin disease that primarily affects the barrier function of the skin in patients. The condition has been documented to cause xerosis in patients from
Published: August 27, 2024 Explor Asthma Allergy. 2024;2:441–449
Asthma is one of the most common respiratory diseases in humans throughout the world. The illness continues to be the most prevalent cause of respiratory morbidity and affects both adults and childr
Published: February 20, 2024 Explor Asthma Allergy. 2024;2:9–32
Chronic rhinosinusitis (CRS) is an inflammatory disorder of the paranasal sinuses and the nasal cavity lasting longer than 12 weeks. This disease is a common clinical syndrome with significant monet
Published: September 19, 2024 Explor Asthma Allergy. 2024;2:473–484
In Europe, allergen products from different manufacturers can be labeled using the same unit with yet different definitions of that unit, which may cause confusion, as is the case for the index of r
Published: August 27, 2023 Explor Asthma Allergy. 2023;1:107–114
Asthma is one of the most common respiratory diseases in humans throughout the world. The illness continues to be the most prevalent cause of respiratory morbidity and affects both adults and childr
Published: February 20, 2024 Explor Asthma Allergy. 2024;2:9–32
Respiratory changes are often associated with anxiety disorders, particularly panic disorder (PD). Individuals experiencing PD are subjected to unexpected panic attacks, marked by overwhelming anxie
Published: April 08, 2024 Explor Asthma Allergy. 2024;2:97–110
Aim:
The impact of complete bilateral nasal obstruction [nasal polyp score (NPS) = 8/8] on treatment outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP) is unclear. This post hoc analys
Published: July 30, 2024 Explor Asthma Allergy. 2024;2:363–372
Aim:
Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis characterized by eosinophilic inflammation. Patients with EGPA are treated with systemic glucocorticoids and immunosuppre
Published: September 19, 2024 Explor Asthma Allergy. 2024;2:461–472
Eosinophilic granulomatosis with polyangiitis (EGPA) is a multiorganic syndrome that affects the cardiovascular, neurologic, renal, and gastrointestinal systems with an incidence ranging from 0 case
Published: June 08, 2023 Explor Asthma Allergy. 2023;1:31–48